华神科技定增募资4.5亿 业务转型应对业绩压力

Group 1: Core Insights - The company plans to issue A-shares at a price of 3.15 yuan per share to raise up to 450 million yuan for working capital and debt repayment, pending shareholder and regulatory approvals [2] - The company is divesting non-core assets and investing in its core business, including a 18 million yuan transfer of a drug license and a 455.56 thousand yuan investment in a related company to expand its moxibustion business [3] - The company reported a revenue of 457 million yuan for the first three quarters of 2025, a year-on-year decline of 31.02%, and a net loss of 97.79 million yuan, prompting strategic asset divestment and increased R&D efforts [4] Group 2: Regulatory and Compliance - The company has had no administrative penalties in the past five years but was ordered to rectify accounting irregularities and non-operating fund usage by the Sichuan Securities Regulatory Bureau in May 2025, with warnings issued to relevant executives [5]